Financials BIO-UV Group

Equities

Market Closed - Euronext Paris Other stock markets 11:35:25 2024-04-26 am EDT			5-day change	1st Jan Change
2.29 ^EUR	-3.78%		-4.38%	-6.34%

Feb. 20	Bio-UV: partnership with U.S.-based Pinnacle Ozone	CF
Jan. 25	Bio-UV: return to growth forecast for 2024	CF

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025
Capitalization ¹	24.92	27.43	69.53	52.95	47.1	23.19	23.19	-
Enterprise Value (EV) ¹	25.88	38.77	70.62	80.55	72	46.14	41.41	38.19
P/E ratio	530 x	-61.4 x	85.1 x	70.8 x	19.6 x	5.65 x	4.98 x	6.54 x
Yield	-	-	-	0.95%	1.29%	2.18%	2.18%	-
Capitalization / Revenue	2.01 x	1.37 x	2.16 x	1.58 x	0.91 x	0.43 x	0.39 x	0.44 x
EV / Revenue	2.08 x	1.94 x	2.19 x	2.4 x	1.4 x	0.86 x	0.69 x	0.73 x
EV / EBITDA	30.1 x	29.5 x	21.4 x	20.7 x	10.3 x	5.26 x	4.02 x	4.35 x
EV / FCF	-6.7 x	-15.5 x	-24.4 x	134 x	-	10.4 x	9.25 x	11 x
FCF Yield	-14.9%	-6.43%	-4.1%	0.74%	-	9.59%	10.8%	9.1%
Price to Book	1.49 x	-	-	-	-	0.61 x	0.53 x	-
Nbr of stocks (in thousands)	7,838	7,838	10,347	10,105	10,097	10,127	10,127	-
Reference price ²	3.180	3.500	6.720	5.240	4.665	2.290	2.290	2.290
Announcement Date	4/11/19	4/29/20	4/7/21	4/6/22	4/3/23	-	-	-

¹EUR in Million²EUR

Estimates

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025
Net sales ¹	12.42	19.98	32.2	33.5	51.5	53.82	59.9	52.59
EBITDA ¹	0.859	1.312	3.3	3.9	7	8.77	10.29	8.786
EBIT ¹	0.0829	-0.3419	1.4	1	4.1	5.8	7.336	5.461
Operating Margin	0.67%	-1.71%	4.35%	2.99%	7.96%	10.78%	12.25%	10.38%
Earnings before Tax (EBT) ¹	-0.197	-0.777	0.5535	0.6313	-	3.342	4.16	4.792
Net income ¹	0.046	-0.4481	0.6	0.7	2.4	4.312	4.86	3.594
Net margin	0.37%	-2.24%	1.86%	2.09%	4.66%	8.01%	8.11%	6.83%
EPS ²	0.006000	-0.0570	0.0790	0.0740	0.2377	0.4050	0.4600	0.3500
Free Cash Flow ¹	-3.864	-2.493	-2.894	0.6	-	4.424	4.478	3.477
FCF margin	-31.13%	-12.48%	-8.99%	1.79%	-	8.22%	7.48%	6.61%
FCF Conversion (EBITDA)	-	-	-	15.38%	-	50.44%	43.51%	39.57%
FCF Conversion (Net income)	-	-	-	85.71%	-	102.6%	92.13%	96.74%
Dividend per Share ²	-	-	-	0.0500	0.0600	0.0500	0.0500	-
Announcement Date	4/11/19	4/29/20	4/7/21	4/6/22	4/3/23	-	-	-

¹EUR in Million²EUR

Estimates

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025
Net Debt ¹	0.96	11.3	1.09	27.6	24.9	22.9	18.2	15
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	1.115 x	8.638 x	0.329 x	7.077 x	3.557 x	2.617 x	1.77 x	1.708 x
Free Cash Flow ¹	-3.86	-2.49	-2.89	0.6	-	4.42	4.48	3.48
ROE (net income / shareholders' equity)	0.41%	-1.46%	2.5%	2.27%	7.61%	14.4%	14.3%	-
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-	-
Book Value Per Share ²	2.140	-	-	-	-	3.740	4.310	-
Cash Flow per Share ²	0.0600	0.1000	0.3200	0.3200	0.2700	0.8100	0.9000	-
Capex ¹	1.97	1.91	3.02	2.7	-	2	1.9	1.8
Capex / Sales	15.87%	9.56%	9.37%	8.06%	-	3.72%	3.17%	3.42%
Announcement Date	4/11/19	4/29/20	4/7/21	4/6/22	4/3/23	-	-	-

¹EUR in Million²EUR

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.29 EUR

Average target price

5.55 EUR

Spread / Average Target

+142.36%